Paper39379679
Disease coverage of human genome-wide association studies and pharmaceutical research and development.
Gordillo-Marañón M and 15 others. Commun Med (Lond), 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Disease coverage of human genome-wide association studies and pharmaceutical research and development. Papers, record 39379679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39379679
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Disease coverage of human genome-wide association studies and pharmaceutical research and development.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed | ||
| PG/22/10989 | British Heart Foundation | United Kingdom | PubMed | |
| FS/17/70/33482 | British Heart Foundation (BHF) | PubMed |
Source PubMed
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33015641 | Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19. | Lancet Rheumatol | 2020 | https://conductscience.org/library/papers/33015641 | PubMed |
| 2 | 21139605 | Towards a knowledge-based Human Protein Atlas. | Nat Biotechnol | 2010 | https://conductscience.org/library/papers/21139605 | PubMed |
| 3 | 34675202 | Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics. | Nat Commun | 2021 | https://conductscience.org/library/papers/34675202 | PubMed |
| 4 | 33644404 | Mendelian randomization for studying the effects of perturbing drug targets. | Wellcome Open Res | 2021 | https://conductscience.org/library/papers/33644404 | PubMed |
| 5 | 31182452 | DBDS Genomic Cohort, a prospective and comprehensive resource for integrative and temporal analysis of genetic, environmental and lifestyle factors affecting health of blood donors. | BMJ Open | 2019 | https://conductscience.org/library/papers/31182452 | PubMed |
| 6 | 22378269 | Diagnosing the decline in pharmaceutical R&D efficiency. | Nat Rev Drug Discov | 2012 | https://conductscience.org/library/papers/22378269 | PubMed |
| 7 | 35433167 | Deep learning tools for advancing drug discovery and development. | 3 Biotech | 2022 | https://conductscience.org/library/papers/35433167 | PubMed |
| 8 | 38632401 | Refining the impact of genetic evidence on clinical success. | Nature | 2024 | https://conductscience.org/library/papers/38632401 | PubMed |
| 9 | 28572223 | Developments in therapy with monoclonal antibodies and related proteins. | Clin Med (Lond) | 2017 | https://conductscience.org/library/papers/28572223 | PubMed |
| 10 | 33328453 | Genetic architecture of host proteins involved in SARS-CoV-2 infection. | Nat Commun | 2020 | https://conductscience.org/library/papers/33328453 | PubMed |
| 11 | 27019110 | Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. | Nat Genet | 2016 | https://conductscience.org/library/papers/27019110 | PubMed |
| 12 | 24518929 | Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of Tartu. | Int J Epidemiol | 2015 | https://conductscience.org/library/papers/24518929 | PubMed |
| 13 | 33045747 | Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33045747 | PubMed |
| 14 | 31830040 | Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. | PLoS Genet | 2019 | https://conductscience.org/library/papers/31830040 | PubMed |
| 15 | 37322032 | Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers. | Nat Commun | 2023 | https://conductscience.org/library/papers/37322032 | PubMed |
| 16 | 28453187 | PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28453187 | PubMed |
| 17 | 32591531 | Genetic drug target validation using Mendelian randomisation. | Nat Commun | 2020 | https://conductscience.org/library/papers/32591531 | PubMed |
| 18 | 34285415 | The PROTACtable genome. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/34285415 | PubMed |
| 19 | 16325682 | Nature's randomised trials. | Lancet | 2005 | https://conductscience.org/library/papers/16325682 | PubMed |
| 20 | 31777672 | Integrating Genetic Data into Electronic Health Records: Medical Geneticists' Perspectives. | Healthc Inform Res | 2019 | https://conductscience.org/library/papers/31777672 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42309052 | Translating genome-wide association studies at multiple scales: Drug target prioritization, cellular architectures, and organ imaging. | Cell Genom | 2026 | https://conductscience.org/library/papers/42309052 | PubMed |
| 42160433 | The immunoproteome and multimorbidity: A Mendelian randomization study. | Sci Adv | 2026 | https://conductscience.org/library/papers/42160433 | PubMed |
| 41735249 | Antiviral drug discovery and development: challenges and future directions. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41735249 | PubMed |
| 40883272 | Clustering of lymphoid neoplasms by cell of origin, somatic mutation and drug usage profiles: a multi-trait genome-wide association study. | Blood Cancer J | 2025 | https://conductscience.org/library/papers/40883272 | PubMed |
| 40594245 | Genome-wide association study of the taste and hedonic ratings of the low-calorie sweetener acesulfame potassium. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594245 | PubMed |
| 39895280 | PROTACs coupled with oligonucleotides to tackle the undruggable. | Bioanalysis | 2025 | https://conductscience.org/library/papers/39895280 | PubMed |
| 39379679 | Disease coverage of human genome-wide association studies and pharmaceutical research and development. | Commun Med (Lond) | 2024 | https://conductscience.org/library/papers/39379679 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39379679
GET https://conductscience.org/api/papers/v1/39379679/references?page=2